Biosimilars- Part 2

Hi everyone, in this post I am continuing with regulation of biosimilars

Some of the regulatory  and scientific issues that are commonly associated with biosimilars are the naming conventions, interchangeability and extrapolation of indications. 528 more words


Translation duets #9: Tammy and Sarah

Note: As part of my final project for Bodies on the Line, a graduate seminar taught by Dr. Harmony Bench in the Department of Dance at OSU, I’m documenting the process of creating a series of duets that address repetition, interchangeability, translation as commentary, and the body as an archive.  505 more words

Ohio State University

Let the Games Begin! FDA Approves Filgrastim Biosimilar

By Robert g. Bell

As many are aware, the Food and Drug Administration (FDA) approved its first biosimilar using the recently enacted abbreviated licensure pathway under… 705 more words

Current Perspectives